Health

  • /

Note: this article is provided by ONU Healthwise Pharmacy.
There's a newly approved treatment for hives.

The US Food and Drug Administration (FDA) has approved Quzyttir (cetirizine) to treat acute urticaria (hives).

Available as an injection to be given into the vein (IV), this new medication is approved for adults and children 6 months of age and older.

Cetirizine injection is now an alternative treatment option to IV diphenhydramine (brand name Benadryl).

The approved dose is once every 24 hours as needed for acute hives.

FDA approves Reyvow (lasmiditan)

  • /

Note: this article is provided by ONU Healthwise Pharmacy.
A new migraine medication is hitting the market.

The US Food and Drug Administration (FDA) has approved Reyvow (lasmiditan) to treat migraines.

Migraines are estimated to affect more than 10 percent of people around the world.

Lasmiditan, available in tablet form, has been approved for adults with migraines with or without aura.

FDA continues to warn consumers of potential risks of vaping

  • /

Note: this article is provided by ONU Healthwise Pharmacy.
Health officials continue to investigate e-cigarettes as the number of reported respiratory problems tied to vaping continues to rise.

Recently, the US Food and Drug Administration (FDA) issued a warning about a possible risk of respiratory issues tied to e-cig products. At the end of August, the FDA stated that 25 states had reported 215 possible cases of such issues.

FDA approves Rybelsus (semaglutide) to treat type 2 diabetes

  • /

Note: this article is provided by ONU Healthwise Pharmacy.
The US Food and Drug Administration (FDA) has approved a new diabetes medication.

This new approval is found under the names Rybelsus (brand name) and semaglutide (active ingredient). The FDA approved semaglutide to treat adults with type 2 diabetes in combination with diet and exercise.

FDA approves pre-measured Gvoke (glucagon) to treat severe low blood sugar

  • /

Note: this article is provided by ONU Healthwise Pharmacy.
Treating severe low blood sugar doesn't have to be complex and overwhelming. And a newly approved treatment may make things even easier.

The US Food and Drug Administration (FDA) has approved Gvoke (glucagon) to be used in emergency instances of severe low blood sugar (hypoglycemia). This new approval, intended for those over the age of 2 who have diabetes, includes the following:

FDA warns of possible cancer-causing impurity in some ranitidine medicines

  • /

Note: this article is provided by the ONU Healthwise Pharmacy.
You may need to check your medicine cabinet for this acid reflux medication.

The US Food and Drug Administration (FDA) has discovered that some medications used for acid reflux contain low levels of a possible cancer-causing impurity.

These medications are found under the names ranitidine (active ingredient) and Zantac (brand). These drugs are available over the counter and via prescription.

Pages